
2 minute read
6 TH NATIONAL CONFERENCE FOR CLINICAL RESEARCH Event report
novel to nobel: better research, better doctors, better health.
Advertisement
by Jasmine leong
th National Conference for Clinical Research (NCCR) was held in Putra World ȋȌǡ Lumpur from the 26 th to 28 th of September 2012.
ϐ ǡ ǯ Lai; Deputy Director General of Health, Support, YBhg Dato’ Dr Ǣ the Director of Clinical Research Centre (CRC), Dr Goh Pik Pin; and the special guest of the event, (From left) Deputy Director General of Health, Research and Technical Support, YBhg Nobel Laureate Professor Ǥ Dato’ Dr Maimunah Abdul Hamid, Minister of Health, Malaysia, YB Dato’ Sri Liow Tiong Lai and Director of Clinical Research Centre, Dr Goh Pik Pin officiating NCCR 2012. NCCR 2012 focused on the need to attract, nurture and retain expertise ϐ meet growing demand for clinical trials from the biopharmaceuticals, medical devices and generics sector. alliance of Asian country-based Clinical Research Organisation (CRO). Asia CRO Alliance (ACA) is a collaboration between China, Japan, India, ǡ Ǥ ǡ Currently, there are 256 industry-sponsored ͳͶͲͳͳͻ clinical trials conducted in public, academic Ǥ and development (R&D) under Budget 2013, “Research evidence plays a key role in decisionmaking and policy formulation in healthcare, ȋȌ improve career pathways and performance ǯȋȌͶͺ Ǥͳ an international clinical trial site with studies booked for 2013 including a large scale study on Alzheimer disease commencing in September 2013 as well as future collaborations with Australia and Japan. incentives for researchers.” said the minister. ǡ Among the local success stories quoted in the ȋȌ Ǧ ȋȌ GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) ȋȌ
Scientific Poster Competition

ȋȌǤ ǯ capacity in clinical research including training for healthcare professionals, enhancement of Standard Operating Procedures (SOPs) critical to the conduct of clinical trials and the inclusion of ǯ plans. infancy and yet promises great potential and opportunities at elevating the overall standard of medical research and healthcare. With great support, effort and direction from the government, industry and academic, translational research could be a very ϐ come.
ABOUT THE AUTHOR: Ǥ ǡ Ǥ ȋͳ st Hons) in ǡ Ǥ from bench to bedside, she has internship experiences with AstraZeneca Sdn. Bhd. and GlaxoSmithKline Consumer Healthcare Sdn. Bhd. in Kuala Lumpur Ǥǡ ȋȌ in Kuala Lumpur. She can be contacted at jasmine@ ϐ Ǥ . Find out more about ϐ ϐǣ ǣȀȀǤ ϐ Ǥ ȀȀ jasmineleong/
REFERENCES: http://www.nccrconference.com.my/fwbPagePublic. jsp?fwbPageId=pIndex
http://www.theborneopost.com/2012/09/27/ health-ministry-hopes-for-bigger-allocation-in-budget/
http://www.verasresearch.com/


LEFT MoU signing ceremony between GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) and the Government of Malaysia represented by the Ministry of Health (MoH) Malaysia through the Clinical Research Centre (CRC). RIGHT Investigator Initiated Research Symposium
looking to promote your research work?
